Jove
Visualize
联系我们

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

635
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
635
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

155
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
155
Cancer Survival Analysis01:21

Cancer Survival Analysis

458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

284
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
284
Multiple Allele Traits01:49

Multiple Allele Traits

35.0K
The Concept of Multiple Allelism
35.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries.

United European gastroenterology journal·2026
Same author

National and State Societal Costs of Schizophrenia in the US in 2024.

JAMA psychiatry·2026
Same author

Value of Treatment for Combat Ocular Trauma.

Military medicine·2025
Same author

Oncologists' preferences for first-line treatment of ALK-positive metastatic NSCLC in the United States: a discrete choice experiment.

Future oncology (London, England)·2025
Same author

Delphi study to elicit expert consensus around decision-making in the treatment of Friedreich ataxia.

Frontiers in neurology·2025
Same author

Criteria Used to Determine Platinum Eligibility in Patients with Metastatic Urothelial Carcinoma: Results of a Physician Survey in Five European Countries.

European urology open science·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Sep 20, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K

实施状细胞疾病的综合风险调整成本效益模型:一个案例研究

Marlon Graf1, Joris Kleintjens2, Md Tahsin Hasan1

  • 1Precision AQ, Bethesda, MD, USA.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 25, 2025
PubMed
概括

综合风险调整成本效益 (GRACE) 方法增强了状细胞疾病基因疗法的成本效益分析. 这种方法揭示了这些治疗方法具有成本效益,改善了社会价值和资源分配.

关键词:
分析成本效益分析.一般化风险调整成本效益 (GRACE) 方法.卫生技术评估 卫生技术评估状细胞疾病是一种状细胞疾病.价值的花朵花的花朵

更多相关视频

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.0K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K

相关实验视频

Last Updated: Sep 20, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.8K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

10.0K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K

科学领域:

  • 卫生经济学 卫生经济学
  • 药物经济学 药物经济学
  • 医疗技术评估 医疗技术评估

背景情况:

  • 传统的成本效益分析 (CEA) 可能低估了针对状细胞病等严重疾病的创新疗法.
  • 社会价值考虑的因素超出了直接成本,包括生活质量和不确定性.

研究的目的:

  • 使用一般化风险调整成本效益 (GRACE) 方法量化治愈状细胞病的社会价值.
  • 为了根据疾病严重程度,治疗结果的不确定性和预期寿命的质量调整成本效益计算.

主要方法:

  • 使用GRACE框架重新校准了状细胞疾病基因疗法 (lovo-cel, exa-cel) 的健康技术评估.
  • 通过根据疾病严重程度和治疗不确定性调整支付意愿门,修改了CEA.

主要成果:

  • 在GRACE的实施下,lovo-cel和exa-cel的增量成本效益比率降低了6%.
  • 在GRACE下,支付意愿门增加了大约50%.
  • 从直接付款人和社会角度来看,Lovo-cel和exa-cel被认为是具有成本效益的.

结论:

  • 格雷斯 (GRACE) 方法提供了对创新疗法的社会价值更全面的估计.
  • 在医疗保健中,GRACE促进了更高效,更公平的资源分配.
  • 这项研究倡导将GRACE元素纳入健康技术评估中,以便更广泛地接受改变生活的治疗方法.